Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1032 | 1032 | 1041 | 1482 | 1322 | 1999 |
Fund Return | 3.18% | 3.18% | 4.05% | 14.01% | 5.74% | 7.17% |
Place in category | 183 | 183 | 112 | 177 | 47 | 20 |
% in Category | 30 | 30 | 19 | 35 | 10 | 8 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Retail Income | 140.83M | 3.04 | 13.40 | 6.57 | ||
UK Equity Income Fund Z Accumulatio | 771.09M | -2.21 | 7.86 | 5.74 | ||
UK Equity Income Fund Z Income GBP | 689.93M | -2.20 | 7.86 | 5.75 | ||
UK Equity Income Fund Retail Accumu | 118.63M | -2.34 | 7.02 | 4.92 | ||
Fund Institutional Income GBP | 416.8K | 5.49 | 7.78 | 9.45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 1.92B | -0.06 | 7.79 | 5.97 | ||
UK Equity Income Fund Retail Income | 140.83M | 3.04 | 13.40 | 6.57 | ||
TB Evenlode Income B Income | 3.33B | 0.05 | 8.44 | 8.51 | ||
UK Equity Income Fund Z Accumulatio | 771.09M | -2.21 | 7.86 | 5.74 | ||
UK Equity Income Fund Z Income GBP | 689.93M | -2.20 | 7.86 | 5.75 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Imperial Brands | GB0004544929 | 7.15 | 1,765.45 | +0.54% | |
RS PLC | GB0003096442 | 6.39 | 733.60 | +0.60% | |
AstraZeneca | GB0009895292 | 4.95 | 10,700.7 | -0.38% | |
Rentokil | GB00B082RF11 | 4.53 | 472.30 | -0.06% | |
3I Group | GB00B1YW4409 | 4.19 | 2,808.51 | +0.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review